Your provider can review your progress, side effects, goals, and available options
Last reviewed: June 27, 2026 Last updated: June 27, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
CloudRx is our partner pharmacy and prescribing service
Angiogenesis / blood flow Both peptides are investigated in animal models for angiogenesis, the new-blood-vessel formation thought to support tissue repair
Dr Hurtado Andrade added: Next, we plan to test these observations in a randomised clinical trial and determine if benefits extend beyond weight loss, specifically, whether hormone therapy also enhances the effects of these medications on cardiometabolic measures
July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)